Shortage continues

alert shortage warning
TGA warns of continuing shortages of an arthritis treatment, but says the situation may be easing The Therapeutic Goods Administration (TGA) says there may be some light at the end of the tunnel with regard to the continuing supply issues around tocilizumab (Actemra). Despite the manufacturer, Roche, advising of ongoing shortages of the arthritis medication,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacists investigated over Facebook posts
Next Research Roundup